Forget Ozempic: This Obesity-Drug Giant Grabs GLP-1 Gold
As GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Cryptocurrency represents a revolutionary digital currency system. Understand its mechanics and implications for your financial decisions.
28,655 articlesAs GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
A focused look at a nuclear energy stock with small modular reactors (SMRs) at the center. Learn the potential upside...
A high-flying AI infrastructure stock surged 176% in a single year. This guide breaks down what powered that move, wh...
Kick off your weekend with a thoughtful set of friday reads designed to inform, not echo headlines. This guide blends...
A fresh, practical look at Marek Capital’s investment playbook. Discover how MiB: Matt Cherwin, Co-Founder and CIO, s...
MaxCyte's 2025 earnings journey hinges on platform momentum, partnerships, and cash discipline. This guide breaks dow...
Inflation can erode returns, but there are smarter ways to shield your portfolio. This guide shows two durable energy...
As CI&T launches into 2026, investors are scanning for momentum, margin resilience, and strategic bets. This deep div...
Cardano has struggled to deliver on big promises, leaving many investors looking for cryptocurrencies that better buy...
Retirement is a chance to design a life with purpose. Explore how varying activities nurture meaning and mental healt...
Investors are watching Meta Platforms for a potential stock split. This guide explains how splits work, what they mea...
Two substantial share sales by Klaviyo's co-CEO in February and March sparked questions about whether this is a warni...